| LY2228820 |
|
| (CAS 862507-23-1) |
 |
| Description： |
LY2228820 is a novel and potent p38MAPK inhibitor (the IC50 for p38αMAPK and p38βMAPK were 7 nM and 3 nM, respectively).
in vivo: In LPS-induced mice, LY2228820 effectively inhibits the formation of TNFα with a threshold minimum 50% effective dose (TMED50) less than 1 mg/kg. In a rat model of collagen-inducedarthritis (CIA), LY2228820 displays potent effects on paw swelling, bone erosion, and cartilage destruction, with a threshold minimum 50% effective dose (TMED50)of 1.5 mg/kg.
|
| Product No. |
KT00518 |
| Product Name |
LY2228820 |
| Synonyms |
|
| Formal Name |
|
| CAS Number |
862507-23-1 |
| Molecular Formula |
C26H37FN6O6S2 |
| Formula Weight |
612.74 |
| Formulation |
A crystalline solid |
| Purity |
98%min |
| Stability |
2 years |
| Storage |
-20°C |
| Shipping |
USD45 for Europe and USA. No shipping charge once amount reach USD500 |
| Quality Control |
HNMR,CNMR,LCMS,HPLC,IR,etc. |
| Price & Availability |
In Stock. Price Negotiated. |
|
| Related Products： |
Doramapimod
Losmapimod
PD 169316
PH-797804
SB 202190
SB 203580
SB 239063
SB 242235
|
|
